HHS Delays 340B Rule Again, Indicates it May Drop it Per Trump Order

Drug Industry Daily
A A
HHS has once again pushed back the effective date of its final rule that would institute fines for drugmakers who overcharge for products covered by a hospital discount program.

To View This Article:

Login

Subscribe To Drug Industry Daily